IBDEI2HZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39880,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,39880,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,39880,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,39881,0)
 ;;=Z80.51^^152^2001^29
 ;;^UTILITY(U,$J,358.3,39881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39881,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,39881,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,39881,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,39882,0)
 ;;=Z83.41^^152^2001^36
 ;;^UTILITY(U,$J,358.3,39882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39882,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,39882,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,39882,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,39883,0)
 ;;=Z81.8^^152^2001^43
 ;;^UTILITY(U,$J,358.3,39883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39883,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,39883,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,39883,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,39884,0)
 ;;=Z81.4^^152^2001^44
 ;;^UTILITY(U,$J,358.3,39884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39884,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,39884,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,39884,2)
 ;;=^5063362
 ;;^UTILITY(U,$J,358.3,39885,0)
 ;;=Z98.0^^152^2001^55
 ;;^UTILITY(U,$J,358.3,39885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39885,1,3,0)
 ;;=3^Intestinal Bypass/Anastomosis Status
 ;;^UTILITY(U,$J,358.3,39885,1,4,0)
 ;;=4^Z98.0
 ;;^UTILITY(U,$J,358.3,39885,2)
 ;;=^5063733
 ;;^UTILITY(U,$J,358.3,39886,0)
 ;;=Z91.128^^152^2001^54
 ;;^UTILITY(U,$J,358.3,39886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39886,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Other Reasons
 ;;^UTILITY(U,$J,358.3,39886,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,39886,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,39887,0)
 ;;=Z77.120^^152^2001^60
 ;;^UTILITY(U,$J,358.3,39887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39887,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,39887,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,39887,2)
 ;;=^5063318
 ;;^UTILITY(U,$J,358.3,39888,0)
 ;;=Z86.74^^152^2001^104
 ;;^UTILITY(U,$J,358.3,39888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39888,1,3,0)
 ;;=3^Personal Hx of Sudden Cardiac Arrest 
 ;;^UTILITY(U,$J,358.3,39888,1,4,0)
 ;;=4^Z86.74
 ;;^UTILITY(U,$J,358.3,39888,2)
 ;;=^5063478
 ;;^UTILITY(U,$J,358.3,39889,0)
 ;;=Z86.718^^152^2001^111
 ;;^UTILITY(U,$J,358.3,39889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39889,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism (DVT)
 ;;^UTILITY(U,$J,358.3,39889,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,39889,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,39890,0)
 ;;=Z96.1^^152^2001^133
 ;;^UTILITY(U,$J,358.3,39890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39890,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,39890,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,39890,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,39891,0)
 ;;=Z96.612^^152^2001^138
 ;;^UTILITY(U,$J,358.3,39891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39891,1,3,0)
 ;;=3^Presence of Left Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,39891,1,4,0)
 ;;=4^Z96.612
 ;;^UTILITY(U,$J,358.3,39891,2)
 ;;=^5063693
 ;;^UTILITY(U,$J,358.3,39892,0)
 ;;=Z96.611^^152^2001^143
